NewBridge Global Ventures, Inc. Appoints Dr. John MacKay as President of 5Leaf Extraction and Elevated Education Operating Subsidiaries

 MacKay is Recognized as Scientific Expert on Extraction

Alameda, California, Oct. 25, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- NewBridge Global Ventures, Inc. (“NewBridge” or the “Company”), (OTCQB: NBGV), a company focused on the emerging and dynamic legal and regulated cannabis industry, today announced that it has appointed Dr. John MacKay as President of the Company’s 5Leaf Extraction and Elevated Education operating subsidiaries. Dr. MacKay’s appointment is effective immediately; he was formally head of NBGV’s Advisory Board.

Dr. MacKay is a widely recognized scientific expert in sub and supercritical fluid for chromeatography and extraction within the botanical space and his career has included many roles in innovative product development.  At 5Leaf Extraction, Dr. Mackay will be leading the team to maximize productivity of work flow for botanical and medical cannabis productions. The 5Leaf process is Formulation Centric in order to produce the highest quality and yields, which is key to this business. He will also oversee the build out of both NewBridge refineries in Oakland and Santa Rosa, California, including quality assurance and quality control, to ensure that both facilities are in full compliance with state and federal laws and regulations.

Bob Bench, Interim President of NewBridge commented, “NewBridge is fortunate to have someone with the stature of Dr. John MacKay leading our important extraction operations. High productivity and quality are key to this business and Dr. MacKay is a recognized expert in the field. We’re so pleased that he chose to join our team, which we believe is a testament to the quality of our fully integrated vertical cannabis platform and its outlook for growth and industry leadership. On behalf of everyone at Newbridge Global Ventures, we welcome Dr. MacKay and look forward to his contributions.”

Dr. MacKay added, “I’m excited to join the leading group of cannabis companies put together by the NewBridge team.  At 5Leaf, I’ll apply my leading scientific skills in the cannabis field to build the Company to a leadership position in extraction. We will focus Elevated Education’s curriculum on the human endocannabinoid system, pharmacology and clinical applications of medical cannabis.”

Dr. MacKay is currently editor and contributing journalist of Extraction Magazine, a cannabis extraction publication, and Terpenes and Testing Magazine, a publication serving the cannabis industry with cannabis news and science on horticulture, extraction and testing labs.  He currently serves as Chief Executive Officer of Synergistic Technologies Associates, LLC, a cannabis consulting firm he founded in March 2017 that is focused on optimizing the work flow for botanical and medical cannabis enterprises. He also serves as the Educator Assistant Professor on the Volunteer Pathway, Department of Pharmacology at The Robert Larner, M.D. College of Medicine at the University of Vermont.  

From 1994 to 2017, Dr. MacKay served in various capacities with Waters Corporation, an analytical laboratory instrument manufacturing company, most recently as Senior Director, Strategic Technologies Marketing Manager.  While recently widely recognized as a scientific expert in sub and supercritical fluid for extraction and chromatography in the botanical space, he is bringing the synergy from what were disparate technologies together to optimize workflow.  Dr. MacKay earned his B.A. in Chemistry from St. Lawrence University and his Ph.D. from the University of Vermont in Inorganic Chemistry focused on the synthesis of cancer fighting compounds.  His career has included many roles in innovative product development. 

About NewBridge Global Ventures

NewBridge Global Ventures, Inc.  (OTCQB: NBGV) is a US public company acquiring and currently operating a vertically integrated portfolio of California cannabis and hemp companies. Our vertical structure includes: genetics, cloning, cultivation, manufacturing, distribution, consulting services to industry entrepreneurs, and education for medical professionals. We believe by focusing on compliance, industry best practices, standardization, and corporate governance NewBridge Global Ventures, Inc. will be squarely positioned for rapid sales growth in the legal California cannabis and industrial hemp Industry. For more information go to:

Forward-Looking Statements

Statements about the expected timing, and all other statements in this press release, other than historical facts, constitute forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements.  Forward-looking statements speak only as of the date hereof and are based on current expectation and involve a number of assumptions, risks and uncertainties that could cause actual results to differ materially from those projected.  A number of the matters discussed herein that are not historical or current facts deal with potential future circumstances and developments that may or may not materialize.  This press release speaks only as of its date, and except as required by law, we disclaim any duty to update.

Contacts:
Bob Bench, Interim President
bob@newbridgegv.com
801-362-2115

Investors:
Stephanie Prince
PCG Advisory Group
sprince@pcgadvisory.com
P: 646.762.4518

Source: NewBridge Global Ventures, Inc.